Drugs / Sodium ferrous citrate
Sodium ferrous citrate
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 22 trials | ||||||
| Phase 2 | NCT07027670 | Feb 2021 → Jun 2022 | aortic valve disorder, coronary artery disorder, mitral valve disorder | University of Oxford | Completed | No outcome recorded |
| Phase 2 | NCT04020653 | Sep 2019 → May 2020 | malaria | Neopharma Japan Co., Ltd. | Withdrawn | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT02481141 | Jul 2014 → Jul 2015 | type 2 diabetes mellitus | SBI Pharmaceuticals Co, Ltd. | Completed | No outcome recorded |
Evidence & citations 13 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sodium ferrous citrate | “A multifaceted treatment approach can include nutritional supplements with antioxidant properties such as 5-aminolevulinic acid (5-ALA) with sodium ferrous citrate (SFC).” PMID 27738640 ↗ Sep 2016 |
| Known as | Fenelmin | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314906 ↗ |
| Known as | Fenilene | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314906 ↗ |
| Known as | Feredaim | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314906 ↗ |
| Known as | Ferromia | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314906 ↗ |
| Known as | Ferrostec | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314906 ↗ |
| Known as | Ferrous sodium citrate | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314906 ↗ |
| Known as | Iromia | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314906 ↗ |
| Known as | Iron(ii) sodium citrate (1:4:2) | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314906 ↗ |
| Known as | SFC | “A multifaceted treatment approach can include nutritional supplements with antioxidant properties such as 5-aminolevulinic acid (5-ALA) with sodium ferrous citrate (SFC).” PMID 27738640 ↗ Sep 2016 |
| Known as | Tetrasodium ferrous dicitrate | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314906 ↗ |
| Modality | Small molecule | — CHEMBL5314906 ↗ |
| Route | Oral | “supplied for oral administration as a dark green, opaque, size 0, HPMC capsule” NCT07027670 ↗ |